These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 9517610)
1. Pulmonary hypertension in POEMS syndrome: a new feature mediated by cytokines. Lesprit P; Godeau B; Authier FJ; Soubrier M; Zuber M; Larroche C; Viard JP; Wechsler B; Gherardi R Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):907-11. PubMed ID: 9517610 [TBL] [Abstract][Full Text] [Related]
2. Pulmonary manifestations in patients with POEMS syndrome: a retrospective review of 137 patients. Allam JS; Kennedy CC; Aksamit TR; Dispenzieri A Chest; 2008 Apr; 133(4):969-74. PubMed ID: 18198255 [TBL] [Abstract][Full Text] [Related]
3. Acute arterial obliteration: a new feature of the POEMS syndrome? Lesprit P; Authier FJ; Gherardi R; Bélec L; Paris D; Melliere D; Schaeffer A; Godeau B Medicine (Baltimore); 1996 Jul; 75(4):226-32. PubMed ID: 8699962 [TBL] [Abstract][Full Text] [Related]
4. POEMS syndrome-related pulmonary hypertension is steroid-responsive. Jouve P; Humbert M; Chauveheid MP; Jaïs X; Papo T Respir Med; 2007 Feb; 101(2):353-5. PubMed ID: 16774822 [TBL] [Abstract][Full Text] [Related]
5. VEGF is causative for pulmonary hypertension in a patient with Crow-Fukase (POEMS) syndrome. Niimi H; Arimura K; Jonosono M; Hashiguchi T; Kawabata M; Osame M; Kitajima I Intern Med; 2000 Dec; 39(12):1101-4. PubMed ID: 11197800 [TBL] [Abstract][Full Text] [Related]
7. [Pro-inflammatory cytokines: a pathogenic key of POEMS syndrome]. Gherardi RK; Authier FJ; Belec L Rev Neurol (Paris); 1996 May; 152(5):409-12. PubMed ID: 8881441 [TBL] [Abstract][Full Text] [Related]
8. Systemic corticosteroids as first-line treatment in pulmonary hypertension associated with POEMS syndrome. Rached S; Athanazio RA; Dias SA; Jardim C; Souza R J Bras Pneumol; 2009 Aug; 35(8):804-8. PubMed ID: 19750334 [TBL] [Abstract][Full Text] [Related]
9. Reversible pulmonary hypertension in POEMS syndrome--another etiology of triggered pulmonary vasculopathy? Paciocco G; Bossone E; Erba H; Rubenfire M Can J Cardiol; 2000 Aug; 16(8):1007-12. PubMed ID: 10978936 [TBL] [Abstract][Full Text] [Related]
10. POEMS syndrome: report on six patients with unusual clinical signs, elevated levels of cytokines, macrophage involvement and chromosomal aberrations of bone marrow plasma cells. Rose C; Zandecki M; Copin MC; Gosset P; Labalette M; Hatron PY; Jauberteau MO; Devulder B; Bauters F; Facon T Leukemia; 1997 Aug; 11(8):1318-23. PubMed ID: 9264387 [TBL] [Abstract][Full Text] [Related]
11. A case of POEMS syndrome with high concentrations of interleukin-6 in pericardial fluid. Shikama N; Isono A; Otsuka Y; Terano T; Hirai A J Intern Med; 2001 Aug; 250(2):170-3. PubMed ID: 11489068 [TBL] [Abstract][Full Text] [Related]
12. Soluble immune mediators in POEMS syndrome with pulmonary hypertension: case report and review of the literature. Feinberg L; Temple D; de Marchena E; Patarca R; Mitrani A Crit Rev Oncog; 1999; 10(4):293-302. PubMed ID: 10654928 [TBL] [Abstract][Full Text] [Related]
13. Growth factors and proinflammatory cytokines in the renal involvement of POEMS syndrome. Soubrier M; Sauron C; Souweine B; Larroche C; Wechsler B; Guillevin L; Piette JC; Rousset H; Deteix P Am J Kidney Dis; 1999 Oct; 34(4):633-8. PubMed ID: 10516342 [TBL] [Abstract][Full Text] [Related]
14. POEMS syndrome with vascular lesions: a role for interleukin-1beta and interleukin-6 increase--a case report. Bova G; Pasqui AL; Saletti M; Bruni F; Auteri A Angiology; 1998 Nov; 49(11):937-40. PubMed ID: 9822051 [TBL] [Abstract][Full Text] [Related]
15. [POEMS syndrome: role and value of interleukin-6]. Andrès E; Courouau F; Kaltenbach G; Maloisel F; Imler M Rev Med Interne; 1996; 17(2):145-9. PubMed ID: 8787086 [TBL] [Abstract][Full Text] [Related]
17. Pulmonary morbidity improves after autologous stem cell transplantation in POEMS syndrome. Chandrashekaran S; Dispenzieri A; Cha SS; Kennedy CC Respir Med; 2015 Jan; 109(1):122-30. PubMed ID: 25433952 [TBL] [Abstract][Full Text] [Related]
18. Arterial obliteration in POEMS syndrome: possible role of vascular endothelial growth factor. Soubrier M; Guillon R; Dubost JJ; Serre AF; Ristori JM; Boyer L; Sauvezie B J Rheumatol; 1998 Apr; 25(4):813-5. PubMed ID: 9558193 [TBL] [Abstract][Full Text] [Related]
19. Elevated levels of interleukin-1 beta (IL-1 beta) and IL-6 in serum and increased production of IL-1 beta mRNA in lymph nodes of patients with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes (POEMS) syndrome. Gherardi RK; Bélec L; Fromont G; Divine M; Malapert D; Gaulard P; Degos JD Blood; 1994 May; 83(9):2587-93. PubMed ID: 8167341 [TBL] [Abstract][Full Text] [Related]
20. Ocular findings in patients with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes syndrome. Kaushik M; Pulido JS; Abreu R; Amselem L; Dispenzieri A Ophthalmology; 2011 Apr; 118(4):778-82. PubMed ID: 21035860 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]